Efficacy Of Lanreotide For The Treatment Of Neuroendocrine Tumors

Efficacy of Lanreotide to Treat Neuroendocrine Tumors

Rare Disease Report

Wolin 2018: Treating NETs & Carcinoid Syndrome With Somatostatin Analogs (SSA)

Neuroendocrine Cancer Awareness Network (NCAN)

Hormone Therapy: Octreotide and Lanreotide

Rocky Mountain Cancer Centers

Dr. Liu on Medical Advancements for Neuroendocrine Tumors

Dr. Kunz on the Impact of Lanreotide’s Approval for Neuroendocrine Tumors

Treatments for Neuroendocrine Tumors

University Hospitals

Why PFS is a Good Outcome Measure for Neuroendocrine Tumors

Rare Disease Report

The Role of Somatostatin Analogs in Neuroendocrine Tumors

Understanding Neuroendocrine Tumors

UChicago Medicine

NETTER-1: Radioactive Octreotide Effective in Metastatic Neuroendocrine Tumors

Rare Disease Report

PLANET: pembrolizumab with lanreotide depot for advanced GEP-NETs

New Treatment for Neuroendocrine Tumors

Treatment for Neuroendocrine Tumors

Overcoming Neuroendocrine Tumor Treatment Challenges

Updates in the management of neuroendocrine cancers

Summary of Clinical Trials for Lanreotide to Treat Carcinoid Syndrome

Rare Disease Report

Somatostatin Analogs in the Treatment of NETs

Managing pancreatic neuroendocrine tumors

Combination and Sequential Treatment in pNETs

Updates in Neuroendocrine Tumors: 2023 Best of GI

Total Health | Oncology